Spots Global Cancer Trial Database for Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy
Official Title: Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy at Cipto Mangunkusumo Hospital and Its Affecting Factors
Study ID: NCT03279900
Conditions
Interventions
Study Description
Brief Summary: This study use an observational study design from patient medical records to obtain data on patient demographics, nutritional status, 6MP dosing, and albumin levels of LLA child patients.
Detailed Description: All medical record data of LLA child patient at maintenance phase therapy, who came to Cipto Mangunkusumo Kiara Hospital in period 2014 - 2016. the data that are colected consist of age, gender, disease stratification, nutritional status, the dosage of 6-MP, albumin levels, hemoglobin levels, leukocyite counts, platelet counts, and absolute neutrophil counts.
Keywords
Eligibility
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cipto Mangunkusomo hospital, Jakarta Pusat, Jakarta, Indonesia
Contact Details
Name: Rianto Setiabudy, Professor
Affiliation: Departemen of Pharmacology and therapeutics, FMUI
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
